Efficient Dual Cas9 Nickase Correction of a Prevalent Pathogenic LAMB 3 Variant for Junctional Epidermolysis Bullosa.
Saved in:
| Title: | Efficient Dual Cas9 Nickase Correction of a Prevalent Pathogenic LAMB 3 Variant for Junctional Epidermolysis Bullosa. |
|---|---|
| Authors: | du Rand A; School of Biological Sciences, The University of Auckland, Auckland, New Zealand.; Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand., Hunt J; School of Biological Sciences, The University of Auckland, Auckland, New Zealand.; Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand., Verdon D; School of Biological Sciences, The University of Auckland, Auckland, New Zealand.; Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand., Buttle B; School of Biological Sciences, The University of Auckland, Auckland, New Zealand., Dunbar PR; School of Biological Sciences, The University of Auckland, Auckland, New Zealand.; Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand., Purvis D; Te Whatu Ora Health New Zealand, Te Toka Tumai, Auckland, New Zealand., Feisst V; School of Biological Sciences, The University of Auckland, Auckland, New Zealand.; Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand., Sheppard H; School of Biological Sciences, The University of Auckland, Auckland, New Zealand.; Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand. |
| Source: | JID innovations : skin science from molecules to population health [JID Innov] 2024 Dec 24; Vol. 5 (3), pp. 100343. Date of Electronic Publication: 2024 Dec 24 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier B.V. on behalf of the Society for Investigative Dermatology Country of Publication: Netherlands NLM ID: 101776173 Publication Model: eCollection Cited Medium: Internet ISSN: 2667-0267 (Electronic) Linking ISSN: 26670267 NLM ISO Abbreviation: JID Innov Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
